Clinical chemistry and laboratory medicine · 2007
Direct determination of selenium in human serum by inductively coupled plasma-collision cell-mass spectrometry.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Burri Judith, Haldimann Max
Аннотация
BACKGROUND: Selenium status in humans depends on nutritional intake. To facilitate a future monitoring study with a large number of samples, an inductively coupled plasma mass spectrometry (ICP-MS) analysis method including collision cell technology was developed for the direct determination of selenium in human serum.
METHODS: Serum samples were diluted (1:15 v/v) with an aqueous solution containing 2-propanol, EDTA(NH(4))(2), ammonia and Triton X-100. Isotope dilution was used as the calibration method, evaluating the (78)Se/(82)Se ratio. Interference by (81)BrH(+) was corrected mathematically. Nebuliser blockage was prevented by sample centrifugation and filtration of the wash solution. Method validation was carried out using certified and spiked human sera.
RESULTS: All values obtained for the accuracy tests were either within the certified ranges or showed recovery between 100.9% and 104.7%. Further results were relative standard deviation of 2.0% for repeatability and 3.0% for between-run precision, a limit of detection of 0.5 mug/L and a limit of quantification of 1.1 microg/L.
CONCLUSIONS: The benefits of the new method are high accuracy combined with low sample consumption and fast sample throughput.
METHODS: Serum samples were diluted (1:15 v/v) with an aqueous solution containing 2-propanol, EDTA(NH(4))(2), ammonia and Triton X-100. Isotope dilution was used as the calibration method, evaluating the (78)Se/(82)Se ratio. Interference by (81)BrH(+) was corrected mathematically. Nebuliser blockage was prevented by sample centrifugation and filtration of the wash solution. Method validation was carried out using certified and spiked human sera.
RESULTS: All values obtained for the accuracy tests were either within the certified ranges or showed recovery between 100.9% and 104.7%. Further results were relative standard deviation of 2.0% for repeatability and 3.0% for between-run precision, a limit of detection of 0.5 mug/L and a limit of quantification of 1.1 microg/L.
CONCLUSIONS: The benefits of the new method are high accuracy combined with low sample consumption and fast sample throughput.